Polaris Oncology Survivor Transition (POST) System
Polaris Oncology Survivor Transition (POST) System
批准号:
8831358
负责人:
Erin Lee O'Hea
金额:
$7.9万
依托单位国家:
美国
项目类别:
财政年份:
2013
资助国家:
美国
项目状态:
已结题
起止时间:
2013-05-10 至 2015-04-30
关键词:
AccreditationAddressAmerican College of SurgeonsAppointmentBackBusinessesCancer EtiologyCancer PatientCancer SurvivorshipCaringCessation of lifeClient satisfactionCommunitiesComputer softwareConsultationsDataData SourcesDevelopmentDiagnosisDistressElectronic Health RecordElectronic MailEvaluationHealthHealth PersonnelHealth behaviorIndividualInstitute of Medicine (U.S.)LaboratoriesLeadLengthLettersLifeLinkLiteratureMalignant NeoplasmsMarketingMassachusettsMedicalMedical HistoryMedical OncologyMental HealthMorbidity - disease rateNatureOncologistOutcomePatientsPhasePhysical FunctionPreventionPrimary Care PhysicianPrimary Health CareProblem SolvingProviderPsychosocial InfluencesPublic HealthPublishingQuality of lifeRecommendationRecurrenceReportingResearch InstituteResourcesRiskRoleScienceSelf AssessmentServicesSmall Business Technology Transfer ResearchSocial supportSpiritualitySupportive careSurvivorsSystemTelefacsimileTestingTextThird-Party PayerTimeUnited StatesUnited States Centers for Medicare and Medicaid ServicesUniversitiesUpdateWomanWritingactive methodbasecancer carecancer recurrencecancer therapyclinical efficacycommercializationcomputerizedcost effectivenessdesignexperiencefollow-upimprovedinnovationinterestmalignant breast neoplasmmedical appointmentmedical schoolsmeetingsmortalityneglectoncologyoncology servicepressureprototypepsychosocialpublic health relevancesuccesssurvivorshiptransmission process
中文摘要
点击翻译按钮获取中文摘要
英文摘要
DESCRIPTION (provided by applicant): The Institute of Medicine (IOM) strongly recommends that all breast cancer patients who are ending active treatment have a "survivorship plan." Such a plan should assist patients in moving back to their primary care physician (PCP), provide advice for reducing risk for cancer recurrence or new cancer development, and address the remaining psychosocial challenges and aftereffects of cancer and cancer treatment. However, because oncology providers are usually very busy, a comprehensive plan is often neglected. This has taken on heightened urgency because new standards published by American College of Surgeons (ACS) require evidence of survivorship planning for accreditation beginning in 2015. Polaris Health Directions (Small Business) and the University of Massachusetts Medical School (UMass, Research Institute) have partnered to solve the problem of poor survivorship planning with the Polaris Oncology Survivor Transition (POST) system. The POST will blend input from the oncology team and a patient self-assessment to create versions of a Survivorship Plan for the oncology provider, PCP, and patient. Each version will contain the following components, but the length and specific content will be dictated by the needs of the end-user: (1) a medical history and oncology treatment summary; (2) a medical plan that lists testing and medical appointments for the next 12 months; (3) personally tailored educational information and referrals related to psychosocial and physical functioning, including the option of a faxed referral to mental health provider for those reporting significant distress; (4) recommendations and resource links pertaining to health behaviors that may improve quality of life and reduce the chance of recurrence; and (5) recommendations and referrals for supportive care, including resources to assist with spirituality and financial concerns. Finally, patients will complete updat assessments at follow up oncology appointments, and the Plan will be adjusted based on new information. The specific aims of Phase 1 are to (1) design and build a prototype of the software, and (2) conduct a field test, refining the prototype iteratively with breast cancer patients and their clinicians until the software meets the target evaluation criteria (n~30). The POST is highly innovative as it will be the first system to produce tailored survivorship plans fuly reflecting IOM and ACS requirements. Furthermore, it will be the first survivorship system to communicate bi-directionally with the EHR, to be driven by both provider and patient input, to allow updates to reflect changes in the patient's condition over time, and to encompass both a medical and a psychosocial summary. Since PCPs currently receive little or no information from the oncology team, the POST's transmission of a Survivorship Plan tailored to meet the PCP's needs is pioneering. The POST's commercialization potential is strong as it can lead to improvements in patient health, help providers perform essential functions more easily and assist organizations in complying with the regulatory standards. Polaris has already established a strong presence in the target market with its distress management product.
期刊论文(2)
专著(0)
科研奖励(0)
会议论文
DOI:
10.1080/07347332.2021.1936336
发表时间:
2022
期刊:
JOURNAL OF PSYCHOSOCIAL ONCOLOGY
影响因子:
2.1
作者:
[O'Hea, Erin L., Creamer, Samantha, Flahive, Julie M., Keating, Beth A., Crocker, Candace R., Williamson, Shannon R., Edmiston, Kathryn L., Harralson, Tina, Boudreaux, Edwin D.]
通讯作者:
Boudreaux, Edwin D.
The Polaris Oncology Survivorship Transition (POST) System: A Patient- and Provider-Driven Cancer Survivorship Planning Program.
Polaris 肿瘤生存过渡 (POST) 系统:患者和提供者驱动的癌症生存规划计划。
DOI:
--
发表时间:
2016
期刊:
Journal of oncology navigation & survivorship
影响因子:
--
作者:
[O'Hea,Erin, Wu,Juliet, Dietzen,Laura, Harralson,Tina, Boudreaux,EdwinD]
通讯作者:
Boudreaux,EdwinD
Polaris Oncology Survivor Transition (POST) System
-
批准号:9147558
-
项目类别:
-
资助金额:$51.42万
-
财政年份:2013
-
负责人:Erin Lee O'Hea
-
依托单位:
Polaris Oncology Survivor Transition (POST) System
-
批准号:8522845
-
项目类别:
-
资助金额:$23.04万
-
财政年份:2013
-
负责人:Erin Lee O'Hea
-
依托单位:
Polaris Oncology Survivor Transition (POST) System
-
批准号:8660664
-
项目类别:
-
资助金额:$6.96万
-
财政年份:2013
-
负责人:Erin Lee O'Hea
-
依托单位:
EFFECTIVE METHODS FOR DISCLOSING BREAST CANCER DIAGNOSIS
-
批准号:7607898
-
项目类别:
-
资助金额:$16.38万
-
财政年份:2007
-
负责人:Erin Lee O'Hea
-
依托单位:
海外基金